Indefinite Delivery Contract SPE2DX15D9371
- Not listed
- The federal contract IDV award SPE2DX15D6907 is an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) and the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $4,999,999.00 single-award IDC, awarded on March 23, 2017, covers the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support...
- The federal contract IDV award SPE2DX15D9251 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $4,999,999 and is valid through December 31, 2025. Through this IDC, DMS Pharmaceutical Group provides a wide range of pharmaceutical products and medical supplies to support the recurring...
- The federal contract IDV award SPE2DX15D9404 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and awarded to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA) under the SPE2DX program, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities...
- The federal contract IDV award SPE2DX15D9154 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $499,999,999, was awarded by the Defense Logistics Agency (DLA) and is valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the medical supply...
- The federal contract IDV award SPE2DX15D9647 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at up to $4,999,999, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables,...
- The federal contract IDV award SPE2DX15D9108 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,999,999 IDC was awarded by the Defense Logistics Agency (DLA) and enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics,...
- The federal contract IDV award with ID SPE2DX15D9373 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, awarded by the Defense Logistics Agency (DLA) under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The IDC covers an...
- The federal contract IDV award SPE2DX15D9215 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,999,999 IDC was awarded by the Defense Logistics Agency (DLA) under the SPE2DX program, with an ultimate completion date of December 31, 2025. The contract enables the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a comprehensive range of...
- The federal contract IDV award SPE2DR25D9957 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999, was awarded by the Defense Logistics Agency (DLA) and is valid through December 2026. The purpose of this IDC is to enable DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs,...
- The federal contract IDV award SPE2DX15D9126 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 IDC, awarded by the Defense Logistics Agency (DLA) under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities...
- SPE2DX15D9371Indefinite Delivery Contract
- 123Federal Contract Awards
This federal contract IDV (SPE2DX15D9371) is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $4,999,999.00 IDC was awarded by the Defense Logistics Agency (DLA) on April 27, 2015 and is valid through December 31, 2025. The contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The task orders cover a diverse portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and other consumable items across various medical domains, including oncology treatments, contraceptives, auto-injectors, and specialized pharmaceuticals. The IDC facilitates direct distribution of these critical pharmaceutical and medical products to Department of Defense sites, positioning DMS Pharmaceutical Group as a key supplier in the federal healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 4/27/15 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order SPE2DX15D9371-SPE2DX18FM6G5 | DMS Pharmaceutical Group Inc. | $1.5k | 1/18/18 | 1/18/18 | 1/18/18 | |
Delivery Order SPE2DX15D9371-B079 | DMS Pharmaceutical Group Inc. | $736 | 7/25/17 | 7/25/17 | 7/25/17 | |
Delivery Order SPE2DX15D9371-SPE2DX18FM6G7 | DMS Pharmaceutical Group Inc. | $1.7k | 2/6/18 | 2/22/18 | 2/6/18 | |
Delivery Order SPE2DX15D9371-SPE2DX18FM6G2 | DMS Pharmaceutical Group Inc. | $5.3k | 12/29/17 | 1/12/18 | 12/29/17 | |
Delivery Order SPE2DX15D9371-B042 | DMS Pharmaceutical Group Inc. | $14.6k | 4/25/16 | 5/5/16 | 4/25/16 |